Presentation TCT 2023 How it Started… How it’s Going. CONFORMAL EFS Clinical Data & CONFORM Trial Update Presenter: William Gray October 25, 2023
Presentation TCT 2023 LV positive reverse remodeling in the TWIST study Presenter: Ehud Schwammenthal October 25, 2023
Presentation TCT 2023 CONFORM Trial Case Review: CLAAS in a Large or Elongated LAA Presenter: Amir Kaki October 25, 2023
Presentation TCT 2023 Standardized Invasive Hemodynamics to Facilitate Lifetime Patient Management Presenter: James Harvey October 25, 2023
Presentation TCT 2023 CLAAS Device Differentiation and Technology Overview Presenter: Shephal Doshi October 25, 2023
Presentation TCT 2023 Contemporary Trends in AS Management Presenter: Philippe Genereux October 25, 2023
News Conference News TCT 2023 More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact Yael L. Maxwell October 24, 2023
Presentation TCT 2023 Position 2: Ischemia and Viability Assessment Remain the Key to Guiding Revascularization Presenter: James Udelson October 24, 2023
Presentation TCT 2023 Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS Presenter: Stephan Windecker October 24, 2023
Presentation TCT 2023 Position 1: Ischemia and Viability Testing Are Overrated – Clinical Judgement Should Guide Patient Management Presenter: William Lombardi October 24, 2023
Presentation TCT 2023 Outcomes of TAVR and SAVR in Bicuspid AS: Data From the STS/TVT Registry Presenter: Tsuyoshi Kaneko October 24, 2023